STOCK TITAN

Penumbra, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Penumbra, Inc. (NYSE: PEN) announced its participation in the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020, at 1:30 PM ET (10:30 AM PT). The event will showcase the company's innovative healthcare solutions. Interested parties can access a webcast of the presentation through the company's website, available for two weeks post-event. Penumbra specializes in designing and market-leading products for challenging medical conditions, primarily serving U.S., Europe, Canada, and Australia.

Positive
  • None.
Negative
  • None.

ALAMEDA, Calif., Nov. 6, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020.

Event:     Canaccord Genuity Virtual MedTech & Diagnostics Forum
Date:       Thursday, November 19, 2020
Time:      1:30pm ET / 10:30am PT

A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com.  The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com.

Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-canaccord-genuity-virtual-medtech--diagnostics-forum-301167651.html

SOURCE Penumbra, Inc.

FAQ

When will Penumbra present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum?

Penumbra will present on November 19, 2020, at 1:30 PM ET.

Where can I watch the Penumbra presentation from the Canaccord Genuity Forum?

The presentation can be accessed on Penumbra's website, available for at least two weeks after the event.

What is the focus of Penumbra's products?

Penumbra focuses on innovative therapies for challenging medical conditions, addressing significant unmet needs in healthcare.

What regions does Penumbra serve?

Penumbra sells its products primarily in the U.S., Europe, Canada, and Australia.

What time does Penumbra's presentation start at the forum?

The presentation starts at 1:30 PM ET / 10:30 AM PT.

Penumbra, Inc.

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Stock Data

9.09B
36.90M
3.85%
93.51%
5.88%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ALAMEDA